The investigational drug brilacidin showed promise in a recent study published in the peer-reviewed journal Viruses. Researchers conclude that the synthetic small molecule from Innovation Pharmaceuticals exhibited “potent antiviral activity.” The scientists tested the drug in a human lung cell line and a monkey cell line. The researchers tested brilacidin against COVID-19 variants from Washington…